微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00853 微创医疗

未开盘 04-18 16:08:15

5.510

+0.060

+1.10%

最高5.620	最低5.250	成交量742.45万
今开5.380	昨收5.450	日振幅6.79%
总市值101.08亿	流通市值101.08亿	总股本18.34亿
成交额4,066万	换手率0.40%	流通股本18.34亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00853","market":"HK","secType":"STK","nameCN":"微创医疗","latestPrice":5.51,"timestamp":1713427695025,"preClose":5.45,"halted":0,"volume":7424513,"delay":0,"floatShares":1834477414,"shares":1834477414,"eps":-2.0508265,"marketStatus":"未开盘","marketStatusCode":0,"change":0.06,"latestTime":"04-18 16:08:15","open":5.38,"high":5.62,"low":5.25,"amount":40656380,"amplitude":0.06789,"askPrice":5.52,"askSize":114600,"bidPrice":5.51,"bidSize":9900,"shortable":3,"etf":0,"ttmEps":-2.127787045086108,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713490200000},"adr":0,"adjPreClose":5.45,"dividendRate":0.007885,"openAndCloseTimeList":[[1713403800000,1713412800000],[1713416400000,1713427200000]],"volumeRatio":0.9001711734597269,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00853","defaultTab":"news","newsList":[{"id":"2427081867","title":"港股异动 | 微创医疗(00853)再跌超5% 短期债务压力缓解 野村称长期债务问题依旧艰难","url":"https://stock-news.laohu8.com/highlight/detail?id=2427081867","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427081867?lang=zh_cn&edition=full","pubTime":"2024-04-16 11:28","pubTimestamp":1713238110,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，微创医疗(00853)再跌超5%，截至发稿，跌4.84%，报5.5港元，成交额2893.47万港元。消息面上，4月5日，微创医疗发布公告称，公司自高瓴资本等机构处取得了一笔最高2亿美元的融资，并将获得3亿美元的借款，以偿还即将到期的4.48亿美元可转债。野村指出，1.5亿美元行使价7.46港元，同时公司必须达到绩效目标。否则，将需要提前偿还高瓴资本5000万美元的贷款。该行认为，短期内情况或有好转，但长期而言依旧艰难。因此，将微创医疗目标价由7.19港元下调至6.71港元，予“中性”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103123.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427869234","title":"微创医疗(00853)股价下跌5.017%，现价港币$5.49","url":"https://stock-news.laohu8.com/highlight/detail?id=2427869234","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427869234?lang=zh_cn&edition=full","pubTime":"2024-04-16 10:19","pubTimestamp":1713233940,"startTime":"0","endTime":"0","summary":"[下跌股]微创医疗(00853) 股价在上午10:19比前收市价下跌5.017%，现股价为港币$5.49。至目前为止，今日最高价为$5.78，而最低价为$5.49。总成交量为296.95万股，总成交金额为港币$1.653千万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404161324/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427506258","title":"南向资金4月15日净卖出微创医疗150.30万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427506258","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427506258?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:31","pubTimestamp":1713231083,"startTime":"0","endTime":"0","summary":"4月15日，南向资金减持微创医疗150.30万股连续3日减持。截止当日收盘，港股通共持有微创医疗50793.36万股，占流通股27.67%。微创医疗近5个交易日下跌12.16%，港股通累计减持251.59万股；近20个交易日下跌23.75%，港股通累计增持917.19万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160942108781e62a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160942108781e62a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427799202","title":"微创医疗获1.5亿美元贷款及超3亿信贷支持，面临业绩扭亏压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2427799202","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2427799202?lang=zh_cn&edition=full","pubTime":"2024-04-13 07:35","pubTimestamp":1712964930,"startTime":"0","endTime":"0","summary":" 微创医疗近日宣布，通过可换股融资获得1.5亿美元贷款，以及金融机构提供的超过3亿美元信贷支持，以解决即将到期的债务问题。根据协议，贷款人有权将贷款转换为换股股份，每股价格为7.46港元。 根据融资协议，微创医疗需在2024年至2026年达成业绩目标，包括在2026年实现扭亏为盈。公司2023年亏损约6.5亿美元，需在今年减亏约58%以达成2024年亏损目标。截至目前，高瓴资本旗下两只基金分别为微创医疗第四和第五大股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041310351687730350&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041310351687730350&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426284054","title":"港股异动 | 微创医疗(00853)尾盘跌近4% 公司获1.5亿美元可换股融资 野村称长期债务问题依旧艰难","url":"https://stock-news.laohu8.com/highlight/detail?id=2426284054","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426284054?lang=zh_cn&edition=full","pubTime":"2024-04-11 15:39","pubTimestamp":1712821170,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，微创医疗(00853)尾盘跌近4%，截至发稿，跌3.92%，报6.12港元，成交额4960.16万港元。消息面上，微创医疗近日宣布，6月份即将到期的4.48亿美元可转债，公司与高瓴资本等贷款人订立可换股融资协议，获得总额为1.5亿美元可换股定期贷款融资，并预计获得金融机构超过3亿美元信贷支持，债务担忧暂得到妥善处理。野村指出，1.5亿美元行使价7.46港元，同时公司必须达到绩效目标。否则，将需要提前偿还高瓴资本5000万美元的贷款。该行认为，短期内情况或有好转，但长期而言依旧艰难。因此，将微创医疗目标价由7.19港元下调至6.71港元，予“中性”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101055.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426468128","title":"直击业绩说明会：高瓴资本暂时“拆弹”，微创医疗董事会称公司无持续经营问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2426468128","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2426468128?lang=zh_cn&edition=full","pubTime":"2024-04-10 17:57","pubTimestamp":1712743020,"startTime":"0","endTime":"0","summary":"10天前发布的2023年业绩显示，微创医疗全年亏损6.49亿美元，亏损程度再扩大10.4%。微创医疗首席财务官孙洪斌在业绩说明会上解释，这一情况属于时间错配，现在可转债再融资已经成功落地，短期银行借款的续借和置换正常可控，经营性现金流也在持续改善，因此董事会及管理层认为集团没有持续经营问题。好在一周后，老股东高瓴资本雪中送炭，微创医疗暂时解除警报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101801077a51dd9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101801077a51dd9f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426243794","title":"高瓴牵头，一举出手10亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2426243794","media":"投资界","top":-1,"share":"https://www.laohu8.com/m/news/2426243794?lang=zh_cn&edition=full","pubTime":"2024-04-10 15:06","pubTimestamp":1712732792,"startTime":"0","endTime":"0","summary":"高瓴输血这家公司又获10亿元微创医疗暂时松了一口气。与之相对，截至2023年末，微创医疗的现金及现金等价物为10.20亿美元，现金流吃紧。而高瓴与微创医疗的渊源，还要从2020年说起——彼时3月，高瓴宣布以每股13.5港元增持微创医疗4773.4万股，耗资6.45亿港元。大手笔增资后，高瓴成为微创医疗第4大股东。不仅如此，在公开增持后，高瓴旗下另一个基金又通过定增拿到微创医疗6600万股股份。而高瓴的这次出手，也客观上为微创医疗提供了新的流动性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410151329875f0444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410151329875f0444&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426435953","title":"短期债务危机解除，微创医疗如何实现三年业绩对赌目标？","url":"https://stock-news.laohu8.com/highlight/detail?id=2426435953","media":"21财经","top":-1,"share":"https://www.laohu8.com/m/news/2426435953?lang=zh_cn&edition=full","pubTime":"2024-04-10 14:11","pubTimestamp":1712729460,"startTime":"0","endTime":"0","summary":"3月28日晚间，微创医疗发布2023年业绩公告。4月5日晚，微创医疗再发公告，对上述部分债务做出初步安排。具体来看，报告期内，微创医疗的一次性、非现金亏损共计2.1亿美元以上，其中1.69亿美元为计提的资产减值。受此影响，2021年，微创医疗心血管介入业务收入下降10.8%至139.5百万美元。此外，微创医疗的骨科业务也受到带量采购的明显影响。2023年内，微创医疗实现营业收入9.51亿美元，同比增长15.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410141407791f93de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410141407791f93de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426515489","title":"市值缩水千亿，“分拆狂魔”借钱还债","url":"https://stock-news.laohu8.com/highlight/detail?id=2426515489","media":"猎云网","top":-1,"share":"https://www.laohu8.com/m/news/2426515489?lang=zh_cn&edition=full","pubTime":"2024-04-10 11:58","pubTimestamp":1712721505,"startTime":"0","endTime":"0","summary":"截至2023年末，微创医疗账上的现金及现金等价物仅为10.19亿美元，偿债压力巨大。版图不断扩容的“微创系”，市值却在缩水，截至发稿，微创医疗的市值只有120.7亿港元，仅是其巅峰时期超千亿市值的一成。12月6日收盘，微创医疗股价为8.68港元，跌幅达24.91%，并拖累整个“微创系”股价。进入2024年，微创医疗再次上演“借新还旧”。在2023年的股东大会上，微创医疗明确表示，公司的长期战略是分拆12家公司独立上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410120246875e0aa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410120246875e0aa0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426113655","title":"五亿美元输血！高瓴伸援手，微创医疗债务警报暂缓解","url":"https://stock-news.laohu8.com/highlight/detail?id=2426113655","media":"蓝鲸财经","top":-1,"share":"https://www.laohu8.com/m/news/2426113655?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:31","pubTimestamp":1712673108,"startTime":"0","endTime":"0","summary":"曾剑指万亿市值的微创医疗，而今不得不借钱还债。财报显示，2024年6月，微创医疗有一笔4.48亿美元的可转债即将到期，且年内，公司还有共计2.95亿美元的短期债务亟待偿还。两笔债务总计7.43亿美元，相当于人民币超50亿元。至此，微创医疗的债务风波得以暂时平息。4月5日，微创医疗公告称，为了偿还4.48亿美元的可转债，公司与原贷款人签订了一份可换股融资协议。除了这笔最高不超过2亿美元的借款外，微创医疗还公布了另一项借款计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/230240","is_publish_highlight":false,"gpt_icon":0},{"id":"2426751181","title":"债务担忧得以缓解，微创医疗(00853)有望迎来转折点","url":"https://stock-news.laohu8.com/highlight/detail?id=2426751181","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426751181?lang=zh_cn&edition=full","pubTime":"2024-04-09 11:54","pubTimestamp":1712634877,"startTime":"0","endTime":"0","summary":"在今年3月2023年报发布后，微创医疗面临的债务负担和现金情况成为投资者眼下的较大担忧。与此同时，微创医疗也与多家金融机构积极沟通，预计将获得金融机构提供的超过3亿美元的信贷支持，用以偿还2026年可换股债券的所有未偿还款项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099835.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426185905","title":"野村：予微创医疗(00853)“中性”评级 目标价降至6.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426185905","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426185905?lang=zh_cn&edition=full","pubTime":"2024-04-09 11:14","pubTimestamp":1712632448,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，野村发布研究报告称，予微创医疗(00853)“中性”评级，目标价从7.19港元下调7%至6.71港元。报告中称，近日微创医疗管理层宣布其偿还可换股债券(CB)的方案，同时提供2024-2026财年的指引。未偿还CB约4.48亿美元，公司向当前可换股债券持有人高瓴资本公司管理层以5.75%年利率发行1.5亿美元的新CB；来自金融机构的3亿美元信贷，管理层认为其利率不会高于6%。根据协议：1）1.5亿美元行使价7.46港元，同时公司必须达到绩效目标。否则，将需要提前偿还高瓴资本5000万美元的贷款。野村认为，短期内情况或有好转，但长期而言依旧艰难。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099816.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426018589","title":"【券商聚焦】野村削微创医疗(00853)目标价6.7%至6.71港元 指长期债务问题依旧艰难","url":"https://stock-news.laohu8.com/highlight/detail?id=2426018589","media":"金吾资讯","top":-1,"share":"https://www.laohu8.com/m/news/2426018589?lang=zh_cn&edition=full","pubTime":"2024-04-09 11:13","pubTimestamp":1712632385,"startTime":"0","endTime":"0","summary":"金吾财讯 | 野村发研报指，微创医疗(00853)管理层近日宣布其偿还可换股债券(CB)的方案，同时提供2024-2026财年的指引。未偿还CB约4.48亿美元，公司向当前可换股债券持有人高瓴资本（Hillhouse Capital）公司管理层以5.75%年利率发行1.5亿美元的新CB；2)来自金融机构的3亿美元信贷，管理阶层认为其利率不会高于6%。该行认为，短期内情况或有好转，但长期而言依旧艰难。因此，将微创医疗目标价由7.19港元下调至6.71港元，予“中性”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091113368b01041b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091113368b01041b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426971253","title":"微创医疗授出合共1164.88万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2426971253","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2426971253?lang=zh_cn&edition=full","pubTime":"2024-04-09 07:52","pubTimestamp":1712620320,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　微创医疗（00853）发布公告，微创医疗科学有限公司董事会按公司于2023年6月19日采纳的股份计划向集团46名合资格参与者及两名服务提供者授出合共1164.88万份购股权以认购最多合共1164.88万股每股面值0.00001美元之普通股，占公司于本公告日期已发行股本约0.635%，惟须待承授人接纳购股权后，方可作实。授出购股权的行使价为每股股份6.58港元。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-09/doc-inareuvy6592820.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-09/doc-inareuvy6592820.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425791613","title":"微创医疗(00853)授出合共1164.88万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2425791613","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2425791613?lang=zh_cn&edition=full","pubTime":"2024-04-08 22:42","pubTimestamp":1712587372,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创医疗(00853)发布公告，微创医疗科学有限公司董事会按公司于2023年6月19日采纳的股份计划向集团46名合资格参与者及两名服务提供者授出合共1164.88万份购股权以认购最多合共1164.88万股每股面值0.00001美元之普通股，占公司于本公告日期已发行股本约0.635%，惟须待承授人接纳购股权后，方可作实。授出购股权的行使价为每股股份6.58港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099700.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2425980846","title":"高瓴加注，微创“拆弹”","url":"https://stock-news.laohu8.com/highlight/detail?id=2425980846","media":"钛媒体APP","top":-1,"share":"https://www.laohu8.com/m/news/2425980846?lang=zh_cn&edition=full","pubTime":"2024-04-08 12:42","pubTimestamp":1712551379,"startTime":"0","endTime":"0","summary":"去年12月6日，微创医疗发布公告称计划赎回6.65亿美元可换股债券。而截至年报披露之日，留给微创医疗找钱还钱的期限仅剩2个月。高瓴与对赌高瓴与微创医疗的渊源，还要从2020年说起。3月初，高瓴宣布以每股13.5港元增持微创医疗4773.4万股，耗资6.45亿港元。这次大手笔增持后，高瓴成为微创医疗第四大股东。这次公开增持后，高瓴旗下另一个基金又通过定增拿到微创医疗6600万股股份。众所周知，微创医疗有一个“中国美敦力”的梦想。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081246538752dc73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081246538752dc73&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425840609","title":"微创医疗(00853)上涨5.47%，报7.14元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2425840609","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425840609?lang=zh_cn&edition=full","pubTime":"2024-04-08 09:30","pubTimestamp":1712539814,"startTime":"0","endTime":"0","summary":"4月8日，微创医疗(00853)盘中上涨5.47%，截至09:30，报7.14元/股，成交766.01万元。微创医疗科学有限公司是一家创新型高端医疗器械集团，主要业务包括心血管及结构性心脏病、电生理及心律管理系统、骨骼与软组织修复科技等十二大业务集群。公司已上市产品400余个，产品已进入全球逾万家医院，平均每6秒就有一个微创的产品被用于救治患者生命或改善其生活品质或用于帮助其催生新的生命。截至2023年年报，微创医疗营业总收入67.34亿元、净利润-33.83亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/08093040141187.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425606260","title":"港股异动 | 微创医疗(00853)高开逾3% 公司获1.5亿美元贷款 拟用于偿还债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2425606260","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2425606260?lang=zh_cn&edition=full","pubTime":"2024-04-08 09:27","pubTimestamp":1712539639,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，微创医疗高开逾3%，截至发稿，涨3.4%，报7港元，成交额494.9万港元。消息面上，微创医疗宣布，获得1.5亿美元可换股定期贷款融资，以偿还2026年可换股债券未偿还款项约4.48亿美元。公告还显示，微创医疗正与多家金融机构沟通，预计获得超3亿美元信贷支持。根据微创医疗此前公布的2023年年报，公司拥有需在2024年6月到期赎回的本金额为4.48亿美元的可换股债券，以及需于2024年到期偿还的短期银行借款2.95亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099129.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2425702326","title":"常兆华秀资本术“拆”出6家上市公司 微创医疗四年亏超90亿陷借新还旧","url":"https://stock-news.laohu8.com/highlight/detail?id=2425702326","media":"长江商报","top":-1,"share":"https://www.laohu8.com/m/news/2425702326?lang=zh_cn&edition=full","pubTime":"2024-04-08 07:59","pubTimestamp":1712534359,"startTime":"0","endTime":"0","summary":"目前微创系已经拥有6家上市公司平台，微创医疗明确表示拆分12家公司独立上市是公司的长期战略。但目前来看，微创系业绩承压，除心脉医疗外，其他5家上市公司或微盈或亏损，其中，微创医疗近四年已累计亏损13.82亿美元，折合人民币超90亿元。截至目前，包括微创医疗在内，常兆华拥有6家上市公司，被资本市场戏称为“分拆王”。目前，由于微创医疗的一笔债务即将到期，常兆华可谓“亚历山大”。巨额债务下，微创医疗“借新还旧”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404080813458751e51e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404080813458751e51e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425614554","title":"微创医疗(00853.HK)获1.5亿美元可换股融资  年息5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425614554","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2425614554?lang=zh_cn&edition=full","pubTime":"2024-04-07 20:10","pubTimestamp":1712491800,"startTime":"0","endTime":"0","summary":"微创医疗(00853.HK) 公布，获贷款人提供本金总额1.5亿美元，年利率5.75%的美元可换股定期贷款融资，另可加码5,000万美元。初始换股价7.46元，较上交易日(5日)收报溢价10.19%；可兑换新股占扩大后股本7.9%。同时，预计将获得金融机构提供的超过3亿美元信贷支持，用以偿还2026年可换股债券的所有未偿还款项。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-05 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190301172933555_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190301172933555_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1340452/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.microport.com.cn","stockEarnings":[{"period":"1week","weight":-0.0952},{"period":"1month","weight":-0.2061},{"period":"3month","weight":-0.1141},{"period":"6month","weight":-0.4982},{"period":"1year","weight":-0.7082},{"period":"ytd","weight":-0.3456}],"compareEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0087},{"period":"3month","weight":0.0704},{"period":"6month","weight":-0.0458},{"period":"1year","weight":-0.1955},{"period":"ytd","weight":-0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微创医疗科学有限公司是一家主要从事医疗产品制造及销售业务的香港投资控股公司。该公司主要通过七大分部运营。骨科医疗器械分部研究、开发、制造及销售骨科医疗器械。心血管介入产品分部研究、开发、生产及销售心血管用器械，如：药物洗脱支架。大动脉与外周介入产品分部研究、开发、生产及销售大动脉及外周血管介入产品。电生理医疗器械分部研究、开发、制造及销售电生理医疗器械。神经介入产品分部研究、开发、生产及销售神经介入产品。外科医疗器械分部研究、开发、制造及销售外科手术器械。糖尿病及内分泌医疗器械分部研究、开发、制造及销售糖尿病相关器械。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.003149},{"month":2,"riseRate":0.428571,"avgChangeRate":0.00486},{"month":3,"riseRate":0.5,"avgChangeRate":0.021886},{"month":4,"riseRate":0.428571,"avgChangeRate":0.019497},{"month":5,"riseRate":0.615385,"avgChangeRate":0.038683},{"month":6,"riseRate":0.461538,"avgChangeRate":0.048139},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.014737},{"month":8,"riseRate":0.307692,"avgChangeRate":-0.046819},{"month":9,"riseRate":0.538462,"avgChangeRate":-0.018994},{"month":10,"riseRate":0.714286,"avgChangeRate":0.032822},{"month":11,"riseRate":0.5,"avgChangeRate":0.015983},{"month":12,"riseRate":0.357143,"avgChangeRate":-0.019332}],"exchange":"SEHK","name":"微创医疗","nameEN":"MICROPORT"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微创医疗(00853)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微创医疗,00853,微创医疗股票,微创医疗股票老虎,微创医疗股票老虎国际,微创医疗行情,微创医疗股票行情,微创医疗股价,微创医疗股市,微创医疗股票价格,微创医疗股票交易,微创医疗股票购买,微创医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微创医疗(00853)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}